z-logo
Premium
Silent and non‐silent thromboembolic events after ventricular tachycardia ablation: Modifiable risk with postprocedure anticoagulation?
Author(s) -
Siontis Konstantinos C.,
Killu Ammar M.
Publication year - 2019
Publication title -
journal of cardiovascular electrophysiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.193
H-Index - 138
eISSN - 1540-8167
pISSN - 1045-3873
DOI - 10.1111/jce.14051
Subject(s) - medicine , ablation , cardiology , atrial fibrillation , catheter ablation , ventricular tachycardia , tachycardia
There is increasing recognition of silent and clinically apparent thromboembolic events after left‐sided ventricular tachycardia (VT) ablation. However, unlike atrial fibrillation ablation procedures where postablation oral anticoagulation (OAC) is universal, there is significant practice variation in OAC use after VT ablation. Herein, we review the data on post‐VT ablation thromboembolism and evidence on the use of OAC, we suggest that OAC merits consideration in most cases after a balanced assessment of risks and benefits in individual patients, and we discuss future directions.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here